| iBio, Inc. (IBIO) |
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 |
| Balance Sheet Date | | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 |
| Fiscal Period | | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 |
| Price to Sales | 874.58x | 866.89x | 219.93x | 146.17x | 31.49x | 31.92x | 105.72x | 57.34x | 108.10x | 80.30x | | | | | 13.59x | 2.15x | 19.80x | 30.12x | 38.80x | 87.46x | 112.40x | 138.74x | 110.89x | 81.64x | 122.94x | 158.97x | 60.64x | 4.58x | 6.50x | 7.12x | 12.99x | 14.45x | 42.46x | 221.92x | 50.74x | 36.20x | 76.74x | | | | | | | | | | | | |
| Price to Book | 1.02x | 1.01x | .85x | .78x | .28x | .86x | 3.48x | 1.55x | 1.07x | .85x | .57x | 4.23x | .63x | .67x | 1.47x | .21x | .77x | .89x | 1.16x | 1.29x | 2.29x | 3.03x | 3.17x | 1.77x | 2.98x | 4.60x | 20.08x | - | - | 5.84x | 2.47x | 1.13x | 1.20x | 6.09x | 6.11x | 2.13x | 4.65x | | | | | | | | | | | | |
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | | | | | | | | | | | | |
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | | | | | | | | | | | | |
| Debt to Asset Ratio | | .14x | .10x | .12x | .13x | .36x | .40x | .36x | .28x | .26x | .50x | .73x | .65x | .63x | .61x | .64x | .43x | .36x | .31x | .28x | .30x | .26x | .27x | .26x | .32x | .40x | .91x | 1.01x | 1.06x | .92x | .81x | .73x | .70x | .62x | .87x | .78x | .81x | .75x | .68x | .61x | .57x | .53x | .55x | .16x | .14x | .10x | .11x | .13x | .18x |
| Current Ratio | | 7.85x | 11.88x | 9.04x | 8.39x | 1.59x | 1.12x | 1.76x | 3.37x | 4.08x | 1.69x | .91x | 1.11x | 1.19x | 1.22x | 1.38x | 1.97x | 1.48x | 7.28x | 8.09x | 11.09x | 15.74x | 17.67x | 18.17x | 16.84x | 11.79x | 1.67x | .84x | .48x | 1.39x | 2.37x | 3.14x | 3.24x | 8.00x | 2.05x | 3.83x | 3.03x | 4.26x | 4.95x | 8.97x | 9.41x | 10.43x | 9.31x | | | 8.01x | | 5.80x | 3.38x |
✓